Preferred and actual place of death in haematological malignancies: a report from the UK haematological malignancy research network
Open Access
- 1 March 2021
- journal article
- research article
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 11 (1), 7-16
- https://doi.org/10.1136/bmjspcare-2019-002097
Abstract
Objectives Hospital death is comparatively common in people with haematological cancers, but little is known about patient preferences. This study investigated actual and preferred place of death, concurrence between these and characteristics of preferred place discussions. Methods Set within a population-based haematological malignancy patient cohort, adults (>= 18 years) diagnosed 2004-2012 who died 2011-2012 were included (n=963). Data were obtained via routine linkages (date, place and cause of death) and abstraction of hospital records (diagnosis, demographics, preferred place discussions). Logistic regression investigated associations between patient and clinical factors and place of death, and factors associated with the likelihood of having a preferred place discussion. Results Of 892 patients (92.6%) alive 2 weeks after diagnosis, 58.0% subsequently died in hospital (home, 20.0%; care home, 11.9%; hospice, 10.2%). A preferred place discussion was documented for 453 patients (50.8%). Discussions were more likely in women (p=0.003), those referred to specialist palliative care (p<0.001), and where cause of death was haematological cancer (p<0.001); and less likely in those living in deprived areas (p=0.005). Patients with a discussion were significantly (p<0.05) less likely to die in hospital. Last recorded preferences were: home (40.6%), hospice (18.1%), hospital (17.7%) and care home (14.1%); two-thirds died in their final preferred place. Multiple discussions occurred for 58.3% of the 453, with preferences varying by proximity to death and participants in the discussion. Conclusion Challenges remain in ensuring that patients are supported to have meaningful end-of-life discussions, with healthcare services that are able to respond to changing decisions over time.Funding Information
- Marie Curie Cancer Care (C38860/A12554)
- Bloodwise (10042)
- National Institute for Health Research (RP-PG-0613-20002)
This publication has 32 references indexed in Scilit:
- Annual report to the nation on the status of cancer, part I: National cancer statisticsCancer, 2020
- Integration of Palliative Care into Acute Myeloid Leukemia CareSeminars in Oncology Nursing, 2019
- Early Palliative Care for Patients with Hematologic Malignancies: Is It Really so Difficult to Achieve?Current Hematologic Malignancy Reports, 2017
- End‐of‐life care: Where do cancer patients want to die? A systematic reviewAsia-Pacific Journal of Clinical Oncology, 2017
- What determines duration of palliative care before death for patients with advanced disease? A retrospective cohort study of community and hospital palliative care provision in a large UK cityBMJ Open, 2016
- The importance of identifying preferred place of deathBMJ Supportive & Palliative Care, 2015
- International study of the place of death of people with cancer: a population-level comparison of 14 countries across 4 continents using death certificate dataBritish Journal of Cancer, 2015
- Factors associated with aggressive end of life cancer careSupportive Care in Cancer, 2015
- Preferred and actual place of death in haematological malignancyBMJ Supportive & Palliative Care, 2015
- Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published dataPalliative Medicine, 2011